drugset / Trial / NCT00992472
Bioavailability of Prochlorperazine Suppositories, 25 mg
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to compare prochlorperazine plasma concentrations produced after administration of the test formulation with those produced after administration of a marketed reference product.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prochlorperazine | Small molecule | 25 mg | Rectal |
Indications
No indication recorded.